Trial NCT01697072

View at ClinicalTrials.gov 
Org. Study IDs: 20070622
Secondary IDs: 2011-004923-11

Last trial update was posted on 2016-02-09

MeSH Interventions

Capecitabine Cisplatin Epirubicin Rilotumumab

MeSH Conditions

Adenocarcinoma Stomach Neoplasms

Other Conditions

Gastric Cancer

Stopping Reasons

All Amgen sponsored AMG102 clinical studies were terminated following a pre-planned Data Monitoring Committee safety review of study 20070622.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID